These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 12475541)
21. [Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Colorectal cancer]. Ito K; Kato T Nihon Igaku Hoshasen Gakkai Zasshi; 2002 May; 62(6):270-7. PubMed ID: 12073633 [TBL] [Abstract][Full Text] [Related]
23. Advances in positron emission tomography imaging for the GI tract. Pham KH; Ramaswamy MR; Hawkins RA Gastrointest Endosc; 2002 Jun; 55(7 Suppl):S53-63. PubMed ID: 12024124 [No Abstract] [Full Text] [Related]
24. Intraoperative sonography still the standard technique in hepatic surgery. Prati U; Trotta F; Roveda L; Filice C AJR Am J Roentgenol; 2002 Nov; 179(5):1347-8; author reply 1348. PubMed ID: 12388531 [No Abstract] [Full Text] [Related]
25. [Positron-emission tomography in oncology]. Zaplatnikov K; Menzel C; Döbert N; Diehl M; Hamscho N; Grünwald F Klin Med (Mosk); 2003; 81(12):13-21. PubMed ID: 14971150 [TBL] [Abstract][Full Text] [Related]
26. Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases. Schüssler-Fiorenza CM; Mahvi DM; Niederhuber J; Rikkers LF; Weber SM J Gastrointest Surg; 2004 Feb; 8(2):150-7; discussion 157-8. PubMed ID: 15036190 [TBL] [Abstract][Full Text] [Related]
27. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. Willkomm P; Bender H; Bangard M; Decker P; Grünwald F; Biersack HJ J Nucl Med; 2000 Oct; 41(10):1657-63. PubMed ID: 11037995 [TBL] [Abstract][Full Text] [Related]
29. [Role of positron emission tomography is the evaluation of digestive tract tumors]. Hustinx R; Paulus P; Daenen F; Detroz B; Honoré P; Jacquet N; Rigo P Rev Med Liege; 1999 Dec; 54(12):925-30. PubMed ID: 10686798 [TBL] [Abstract][Full Text] [Related]
30. High predictive value of F-18 FDG PET patterns of the spine for metastases or benign lesions with good agreement between readers. Bohdiewicz PJ; Wong CY; Kondas D; Gaskill M; Dworkin HJ Clin Nucl Med; 2003 Dec; 28(12):966-70. PubMed ID: 14663317 [TBL] [Abstract][Full Text] [Related]
31. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Arulampalam T; Costa D; Visvikis D; Boulos P; Taylor I; Ell P Eur J Nucl Med; 2001 Dec; 28(12):1758-65. PubMed ID: 11734912 [TBL] [Abstract][Full Text] [Related]
37. [Thoracic radiography in colorectal cancer staging 3]. Bülow S Ugeskr Laeger; 2006 Feb; 168(9):929-30. PubMed ID: 16513067 [No Abstract] [Full Text] [Related]
38. 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Chin BB; Wahl RL Gut; 2003 Jun; 52 Suppl 4(Suppl 4):iv23-9. PubMed ID: 12746265 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies. Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131 [TBL] [Abstract][Full Text] [Related]
40. Decision analysis for the cost-effective management of recurrent colorectal cancer. Park KC; Schwimmer J; Gambhir SS Ann Surg; 2002 Feb; 235(2):309-10; author reply 310. PubMed ID: 11807375 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]